LABORATOIRES THEA
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)
- First Posted Date
- 2021-12-15
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 7
- Registration Number
- NCT05158296
- Locations
- 🇺🇸
Emory Eye Center, Atlanta, Georgia, United States
🇺🇸Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Center for Clinical Research Operations, Massachusetts Eye and Ear, Boston, Massachusetts, United States
An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa
- Conditions
- Interventions
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 21
- Registration Number
- NCT05085964
- Locations
- 🇺🇸
Retina Foundation of the Southwest, Dallas, Texas, United States
🇺🇸University of Michigan, Kellogg Eye Center, Ann Arbor, Michigan, United States
🇺🇸Center for Clinical Research Operations, Massachusetts Eye and Ear, Boston, Massachusetts, United States
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.
- Conditions
- Interventions
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 554
- Registration Number
- NCT04898387
- Locations
- 🇧🇬
Medical Center Vereya EOOD, Stara Zagora, Bulgaria
Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment
- Conditions
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 310
- Registration Number
- NCT04803240
- Locations
- 🇬🇧
University of Plymouth, Plymouth, United Kingdom
Efficacy and Tolerability of Blephademodex Wipes
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 50
- Registration Number
- NCT04780165
- Locations
- 🇩🇪
Consultation office, Heidelberg, Germany
Macula Evolution in Patients With AMD Taking Oral Food Supplementation
- Conditions
- Interventions
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 10
- Registration Number
- NCT04778436
- Locations
- 🇫🇷
Wilfried Roquet, Clermont-Ferrand, France
Gastrointestinal Tolerance Assessment of T2309
- Conditions
- Interventions
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 55
- Registration Number
- NCT04596605
- Locations
- 🇫🇷
Centre Investigation Clinique, Nantes, France
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2021-07-14
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 31
- Registration Number
- NCT04552964
- Locations
- 🇫🇷
Centre d'Ophtalmologie Blatin, Clermont-Ferrand, France
Extension Study to Study PQ-110-001 (NCT03140969)
- First Posted Date
- 2019-04-12
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 9
- Registration Number
- NCT03913130
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇧🇪Ghent University Hospital and Ghent University, Ghent, Belgium
🇺🇸Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States
Efficacy of T2259 in DED
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 101
- Registration Number
- NCT03874429
- Locations
- 🇫🇷
C.H.N.O des XV-XX, Paris, France